• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乳腺癌中经历扩增、过表达和融合的BCAS3(17q23)和BCAS4(20q13)基因的克隆。

Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.

作者信息

Bärlund Maarit, Monni Outi, Weaver J Donald, Kauraniemi Päivikki, Sauter Guido, Heiskanen Mervi, Kallioniemi Olli-P, Kallioniemi Anne

机构信息

Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.

出版信息

Genes Chromosomes Cancer. 2002 Dec;35(4):311-7. doi: 10.1002/gcc.10121.

DOI:10.1002/gcc.10121
PMID:12378525
Abstract

In breast cancer, several chromosomal sites frequently undergo amplification, implicating the location of genes important for tumor development and progression. Here we cloned two novel genes, breast carcinoma amplified sequence 3 (BCAS3) and 4 (BCAS4), from the two most common amplification sites in breast cancer, 17q23 and 20q13. The BCAS3 gene at 17q23 spans more than 600 kb at the genomic level and was predicted to encode a 913 amino acid nuclear protein. The BCAS4 gene at 20q13.2 encodes a 211 amino acid cytoplasmic protein. Both BCAS3 and BCAS4 represent novel genes with no homologies to any other known gene or protein. In the MCF7 breast cancer cell line, the BCAS3 and BCAS4 genes were co-amplified, and cloning of a highly overexpressed 1.3-kb transcript revealed a rearrangement fusing the last two exons of BCAS3 with BCAS4. The fusion led to a novel message in which only the first exon of BCAS4 and part of exon 23 of BCAS3 were transcribed. The BCAS4-BCAS3 fusion transcript was detected only in MCF7 cells, but the BCAS4 gene was also overexpressed in nine of 13 breast cancer cell lines. In conclusion, our results indicate that these novel genes, BCAS3 at 17q23 and BCAS4 at 20q13.2, undergo amplification, overexpression, and fusion in breast cancer and therefore may have a role in the frequent chromosomal alterations affecting these two loci.

摘要

在乳腺癌中,几个染色体位点经常发生扩增,这表明了对肿瘤发生和进展至关重要的基因所在位置。在此,我们从乳腺癌中两个最常见的扩增位点17q23和20q13克隆了两个新基因,即乳腺癌扩增序列3(BCAS3)和4(BCAS4)。位于17q23的BCAS3基因在基因组水平上跨度超过600 kb,预计编码一个含913个氨基酸的核蛋白。位于20q13.2的BCAS4基因编码一个含211个氨基酸的胞质蛋白。BCAS3和BCAS4均代表与任何其他已知基因或蛋白质无同源性的新基因。在MCF7乳腺癌细胞系中,BCAS3和BCAS4基因共同扩增,对一个高度过表达的1.3 kb转录本进行克隆,结果显示BCAS3的最后两个外显子与BCAS4发生重排融合。这种融合产生了一个新的转录本,其中仅转录了BCAS4的第一个外显子和BCAS3的第23外显子的一部分。BCAS4 - BCAS3融合转录本仅在MCF7细胞中检测到,但BCAS4基因在13个乳腺癌细胞系中的9个中也过表达。总之,我们的结果表明,位于17q23的BCAS3和位于20q13.2的BCAS4这两个新基因在乳腺癌中发生扩增、过表达和融合,因此可能在影响这两个位点的频繁染色体改变中发挥作用。

相似文献

1
Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.在乳腺癌中经历扩增、过表达和融合的BCAS3(17q23)和BCAS4(20q13)基因的克隆。
Genes Chromosomes Cancer. 2002 Dec;35(4):311-7. doi: 10.1002/gcc.10121.
2
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.人类肺泡软组织肉瘤的der(17)t(X;17)(p11;q25)将TFE3转录因子基因与位于17q25的一个新基因ASPL融合。
Oncogene. 2001 Jan 4;20(1):48-57. doi: 10.1038/sj.onc.1204074.
3
Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.原发性乳腺癌中17q12 - 23区域的详细基因拷贝数及RNA表达分析
Genes Chromosomes Cancer. 2003 Apr;36(4):382-92. doi: 10.1002/gcc.10138.
4
A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.位于20号染色体q13区域的一个假定的丝氨酸/苏氨酸激酶编码基因BTAK在人乳腺癌细胞系中被扩增并过表达。
Oncogene. 1997 May 8;14(18):2195-200. doi: 10.1038/sj.onc.1201065.
5
Prognosis and gene expression profiling of 20q13-amplified breast cancers.20q13扩增型乳腺癌的预后与基因表达谱分析
Clin Cancer Res. 2006 Aug 1;12(15):4533-44. doi: 10.1158/1078-0432.CCR-05-2339.
6
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.乳腺肿瘤细胞系中的相互易位:靶向FHIT基因的t(3;20)的克隆
Genes Chromosomes Cancer. 2002 Nov;35(3):204-18. doi: 10.1002/gcc.10107.
7
Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.位于17号染色体长臂23区的多个基因在乳腺癌中发生扩增并过度表达。
Cancer Res. 2000 Oct 1;60(19):5340-4.
8
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.WWOX是一种新的含WW结构域的蛋白质,定位于人类染色体16q23.3 - 24.1,该区域在乳腺癌中经常受到影响。
Cancer Res. 2000 Apr 15;60(8):2140-5.
9
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.通过cDNA微阵列在乳腺癌的ERBB2扩增子中发现的新的扩增且高表达基因。
Cancer Res. 2001 Nov 15;61(22):8235-40.
10
Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.PS6K在染色体区域17q23的定位及其在乳腺癌中的扩增测定。
Cancer Res. 1999 Apr 1;59(7):1408-11.

引用本文的文献

1
Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development.鲁迪拉介导的微管稳定性在小鼠血管发育过程中控制转化生长因子β信号传导。
Elife. 2025 May 15;13:RP98257. doi: 10.7554/eLife.98257.
2
Exploring the Expression of BCAS3 in Head and Neck Squamous Cell Carcinoma and Its Association With Prognosis.探讨BCAS3在头颈部鳞状细胞癌中的表达及其与预后的关系。
Cureus. 2023 Dec 23;15(12):e50995. doi: 10.7759/cureus.50995. eCollection 2023 Dec.
3
Genetic Discrimination of Grade 3 and Grade 4 Gliomas by Artificial Neural Network.
基于人工神经网络的 3 级和 4 级脑胶质瘤的遗传歧视。
Cell Mol Neurobiol. 2023 Dec 27;44(1):13. doi: 10.1007/s10571-023-01448-z.
4
Attention-based deep clustering method for scRNA-seq cell type identification.基于注意力机制的深度聚类方法在 scRNA-seq 细胞类型鉴定中的应用。
PLoS Comput Biol. 2023 Nov 10;19(11):e1011641. doi: 10.1371/journal.pcbi.1011641. eCollection 2023 Nov.
5
Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.尿细胞外囊泡的蛋白质组学分析可区分乳腺癌患者与健康女性。
PLoS One. 2023 Nov 3;18(11):e0291574. doi: 10.1371/journal.pone.0291574. eCollection 2023.
6
The KMT2A recombinome of acute leukemias in 2023.2023 年急性白血病中的 KMT2A 重排组。
Leukemia. 2023 May;37(5):988-1005. doi: 10.1038/s41375-023-01877-1. Epub 2023 Apr 5.
7
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.诱导表达 MyD88 L265P 突变的弥漫性大 B 细胞淋巴瘤细胞的转录组分析鉴定出上调的 CD44、LGALS3、NFKBIZ 和 BATF 作为致癌 NF-κB 信号下游的靶标。
Int J Mol Sci. 2023 Mar 15;24(6):5623. doi: 10.3390/ijms24065623.
8
Somatic Mutation Profiling in Head and Neck Paragangliomas.头颈部副神经节瘤的体细胞突变分析。
J Clin Endocrinol Metab. 2022 Jun 16;107(7):1833-1842. doi: 10.1210/clinem/dgac250.
9
Identification and Analysis of // Competing Endogenous RNA Axis in Late-Onset Alzheimer's Disease Using Bioinformatic and Experimental Approaches.使用生物信息学和实验方法鉴定和分析晚发性阿尔茨海默病中的竞争性内源性RNA轴
Front Aging Neurosci. 2022 Feb 21;14:812169. doi: 10.3389/fnagi.2022.812169. eCollection 2022.
10
BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.BCAS3 通过促进 CRL4A 介导的泛素化作用促进乳腺癌中的 p53 致癌。
Cell Prolif. 2021 Aug;54(8):e13088. doi: 10.1111/cpr.13088. Epub 2021 Jul 9.